[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (846)

Search Parameters:
Keywords = pilot point

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
15 pages, 1143 KiB  
Article
“Vis-à-Vis Training” to Improve Emotional and Executive Competences in Very Preterm Children: A Pilot Study and Randomised Controlled Trial
by Maria Chiara Liverani, Vanessa Siffredi, Greta Mikneviciute, Emma Mazza, Russia Ha-Vinh Leuchter, Petra Susan Hüppi, Cristina Borradori Tolsa and Edouard Gentaz
Children 2024, 11(8), 956; https://doi.org/10.3390/children11080956 - 8 Aug 2024
Viewed by 330
Abstract
Background/Objectives: Premature birth can lead to socio-emotional, behavioural and executive problems that impact quality of life and school performance in the long term. The aim of this pilot study was to evaluate the feasibility and efficacy of a 12-week computerised training called Vis-à-vis [...] Read more.
Background/Objectives: Premature birth can lead to socio-emotional, behavioural and executive problems that impact quality of life and school performance in the long term. The aim of this pilot study was to evaluate the feasibility and efficacy of a 12-week computerised training called Vis-à-vis to enhance these competencies in a cohort of very preterm (VPT) children aged 6 to 9. Methods: This pilot randomised controlled trial included 45 children born before 32 gestational weeks. Socio-emotional, behavioural and executive competencies were evaluated at three time points using computerised tasks, neuropsychological tests and questionnaires. Results: Among the eligible VPT children, 20% (n = 45) accepted to be part of the study, and 40% (n = 18) dropped out. Finally, 60% (n = 27) of the enrolled participants completed the study. Results showed a significant improvement in emotion knowledge and recognition immediately after the completion of the training. Conclusions: Overall, our results indicate that the implementation of this type of computerised training is feasible, but the overall compliance is unsatisfactory given the high dropout rate. Nevertheless, the positive effect of the training on emotion recognition encourages further exploration of these kinds of interventions to prevent adverse consequences in children born too soon. Full article
(This article belongs to the Section Pediatric Neurology & Neurodevelopmental Disorders)
Show Figures

Figure 1

Figure 1
<p>CONSORT diagram detailing participant flow.</p>
Full article ">Figure 2
<p>Randomised controlled trial design of the study.</p>
Full article ">
24 pages, 4644 KiB  
Article
Feasibility of Adjunct Therapy with a Robotic Hand Orthosis after Botulinum Toxin Injections in Persons with Spasticity: A Pilot Study
by Raffaele Ranzani, Margherita Razzoli, Pierre Sanson, Jaeyong Song, Salvatore Galati, Carlo Ferrarese, Olivier Lambercy, Alain Kaelin-Lang and Roger Gassert
Toxins 2024, 16(8), 346; https://doi.org/10.3390/toxins16080346 - 8 Aug 2024
Viewed by 442
Abstract
Upper-limb spasticity, frequent after central nervous system lesions, is typically treated with botulinum neurotoxin type A (BoNT-A) injections to reduce muscle tone and increase range of motion. However, performing adjunct physical therapy post-BoNT-A can be challenging due to residual weakness or spasticity. This [...] Read more.
Upper-limb spasticity, frequent after central nervous system lesions, is typically treated with botulinum neurotoxin type A (BoNT-A) injections to reduce muscle tone and increase range of motion. However, performing adjunct physical therapy post-BoNT-A can be challenging due to residual weakness or spasticity. This study evaluates the feasibility of hand therapy using a robotic hand orthosis (RELab tenoexo) with a mobile phone application as an adjunct to BoNT-A injections. Five chronic spastic patients participated in a two-session pilot study. Functional (Box and Block Test (BBT), Action Research Arm Test (ARAT)), and muscle tone (Modified Ashworth Scale (MAS)) assessments were conducted to assess functional abilities and impairment, along with usability evaluations. In the first session, subjects received BoNT-A injections, and then they performed a simulated unsupervised therapy session with the RELab tenoexo in a second session a month later. Results showed that BoNT-A reduced muscle tone (from 12.2 to 7.4 MAS points). The addition of RELab tenoexo therapy was safe, led to functional improvements in four subjects (two-cube increase in BBT as well as 2.8 points in grasp and 1.3 points in grip on ARAT). Usability results indicate that, with minor improvements, adjunct RELab tenoexo therapy could enhance therapy doses and, potentially, long-term outcomes. Full article
(This article belongs to the Special Issue The Botulinum Toxin and Spasticity: Exploring New Horizons)
Show Figures

Figure 1

Figure 1
<p>Checklist results represented as a heatmap. The results averaged over the subjects, and items are presented on the right and at the bottom of the heat map, respectively. The items “DN”, “CO”, and “DF” were evaluated during the assessments at S0 and S1, the other items only at S1. The tasks are ranked successful (1, green, i.e., no problem/issue in item completion without external intervention) or failed (0, red, i.e., failure and/or external intervention required to solve the item). Intermediate nuances between green and red are average values (Av) between 0 and 1 over subjects and items, respectively. DN: donning; CO: start-up and control; TH: all therapy exercises; ST: Stretching; PY: Pyramid; PA: Painting; *: item that could not be performed without external intervention before BoNT-A injections (S0) but could be performed after BoNT-A injections (S1).</p>
Full article ">Figure 2
<p>Subject one performing the painting exercise (difficulty level 2) and the resulting sheet after 10 min of exercise.</p>
Full article ">Figure 3
<p>Box and Block Test box-plot results for all five subjects (<b>A</b>) and for the four subjects with muscle hypertonia in finger flexors (i.e., MAS ≥ 1) (<b>B</b>). On the left of the black line are the results at the baseline (S0), while on the right of the line are the changes in performance when using the RELab tenoexo before BoNT-A injections (S0), four to six weeks after BoNT-A injections without RELab tenoexo (S1), and adjunct BoNT-A injections and RELab tenoexo (S1). °: individual scores; ×: mean value.</p>
Full article ">Figure 4
<p>Action Research Arm Test (ARAT) results for all the subjects (<b>top</b>) and for the four subjects with muscle hypertonia in finger flexors (i.e., MAS ≥ 1) (<b>bottom</b>). On the left of the black line are the results at the baseline (S0), while on the right of the line are the changes in performance when using the RELab tenoexo (S0), BoNT-A injections (S1), and adjunct BoNT-A injections and RELab tenoexo (S1). °: individual scores; ×: mean value.</p>
Full article ">Figure 5
<p>One of the study participants (subject 5) performs the hand muscle tone assessment with ReHandyBot (RHB), a haptic device including a physical (i.e., instrumented finger pads) and a graphical user interface to perform assessments and therapy exercises. During the muscle tone assessment, the subject has to relax their hand while the robot applies six 150 ms hand opening perturbations of 20 mm amplitude.</p>
Full article ">Figure 6
<p>RELab tenoexo overview: the RELab tenoexo can be worn by the user or mounted on a wheelchair (<b>left</b>). The hand module (148 g) can be placed on a user’s hand using a glove with Velcro and button-clips and is actuated by motors placed in the actuation unit (720 g) together with the electronics. Different intention detection strategies (e.g., push button, mobile phone application) can be used to trigger the motion of the RHO (<b>right</b>).</p>
Full article ">Figure 7
<p>Grasp functions of the RELab tenoexo (adapted from [<a href="#B31-toxins-16-00346" class="html-bibr">31</a>]): the compliant structure of the finger mechanism allows for adapting to the shape of different objects. Four grasp types (denomination according to [<a href="#B71-toxins-16-00346" class="html-bibr">71</a>]) can be executed with the RELab tenoexo by moving the thumb slider at the back of the hand module from medial to lateral.</p>
Full article ">Figure 8
<p>RELab tenoexo mobile phone application. (<b>A</b>) Main screen offering five functions: (<b>i</b>) battery information, (<b>ii</b>) emergency stop, (<b>iii</b>) opening and closing of the hand, (<b>iv</b>) changing of the grip type (i.e., cylindrical grip, key grip), and (<b>v</b>) force selection. (<b>B</b>) Therapy screen: the user can navigate between different therapy exercises (represented with an icon and a short description (<b>i</b>)) using left/right arrows (<b>ii</b>) and start the exercise with the green button (<b>iii</b>). During the exercise, the application records end-point accelerations from an XSens DOT accelerometer, which can be attached to the dorsum of the RELab tenoexo, but this feature was not used for the scope of this study.</p>
Full article ">Figure 9
<p>Example of therapy setup with the RELab tenoexo. (<b>A</b>) Based on a predefined therapy plan (i), the user can use the mobile phone application (ii) to perform a set of therapy exercises with the RELab tenoexo (iii). (i.e., Cleaning (iv), Pyramid (v)). Mildly impaired subjects will perform fine functional tasks (i.e., Puzzle (vi), Painting (vii)). (<b>B</b>) The therapy exercises have increasing difficulty, depending on the subject’s ability level. Severely impaired subjects will perform hand opening–closing motor training or the Stretching exercise. Moderately impaired subjects will perform gross functional tasks requiring the recruitment of hand and proximal upper limb joints. (<b>C</b>) Tabular therapy plan used in the study. Participants identified “Wednesday” and performed the three 10 min mandatory exercises: Stretching, Pyramid (difficulty level 1: glasses of 3 cm), and Painting (difficulty level 2).</p>
Full article ">Figure 10
<p>The pilot study consisted of two sessions, S0 and S1. In the morning of S0, subjects performed baseline assessments while the experimenter evaluated whether the subject could autonomously don/doff and control the RELab tenoexo using the mobile phone application. In the afternoon, subjects received BoNT-A injections. After four to six weeks (session S1), when the BoNT-A effect peaks, the subjects repeated the assessments. In the afternoon, they performed a simulated unsupervised therapy session with the RELab tenoexo consisting of three 10 min exercises (Stretching, Pyramid, and Painting) performed with the mobile phone application while the experimenter recorded which tasks the subject could not perform autonomously. At the end of the study, the subjects answered usability questionnaires. * = assessment performed with and without the RELab tenoexo. Abbreviations: MAS = Modified Ashworth Scale, BBT = Box and Block Test, SUS = System Usability Scale, rawTLX = raw Task Load Index, MAUQ = mHealth App Usability Questionnaire, QUEST 2.0 = Quebec User Evaluation of Satisfaction with Assistive Technology 2.0.</p>
Full article ">
11 pages, 486 KiB  
Article
MALAMA: Cultivating Food Sovereignty through Backyard Aquaponics with Native Hawaiian Families
by Jane J. Chung-Do, Phoebe W. Hwang, Ilima Ho-Lastimosa, Ikaika Rogerson, Kenneth Ho, Kauʻi DeMello, Dwight Kauahikaua and Hyeong Jun Ahn
Genealogy 2024, 8(3), 101; https://doi.org/10.3390/genealogy8030101 - 7 Aug 2024
Viewed by 288
Abstract
Native Hawaiians were a healthy and robust population who developed a sophisticated food system that was dismantled by colonization. Currently, Native Hawaiians face pervasive health disparities due to the limited access to healthy foods and lifestyles. This study pilot tested a family-based community-driven [...] Read more.
Native Hawaiians were a healthy and robust population who developed a sophisticated food system that was dismantled by colonization. Currently, Native Hawaiians face pervasive health disparities due to the limited access to healthy foods and lifestyles. This study pilot tested a family-based community-driven intervention called MALAMA, which teaches families to build and use a backyard aquaponics system to grow their own food. A total of 21 participants from 10 families completed a three-month curriculum that included a series of hands-on workshops. Participant attendance was recorded and participants completed a behavioral health questionnaire as well as provided clinical indicators at three time points. They also attended a focus group at the end of the curriculum. There was a high level of engagement and no participant attrition. Fruit consumption among all participants significantly increased and there were favorable trends in blood pressure and fish and vegetable consumption. No significant differences were found in the other clinical indicators. Participants found MALAMA to be highly culturally acceptable and identified multiple benefits. Community-driven solutions, such as MALAMA, may be a promising approach to addressing pervasive health disparities and promoting health equity in minority and Indigenous communities. Full article
Show Figures

Figure 1

Figure 1
<p>Proportion of participants who attended MALAMA by workshop.</p>
Full article ">
8 pages, 1190 KiB  
Article
Evaluating the Correlation between Myofascial Pelvic Pain and Female Sexual Function: A Prospective Pilot Study
by Lejla Sandrieser, Jana Heine, Christine Bekos, Alexandra Perricos-Hess, René Wenzl, Heinrich Husslein and Lorenz Kuessel
J. Clin. Med. 2024, 13(16), 4604; https://doi.org/10.3390/jcm13164604 - 6 Aug 2024
Viewed by 404
Abstract
Introduction: Myofascial pelvic pain (MFPP) is a prevalent yet frequently overlooked condition characterized by myofascial trigger points located within the pelvic floor muscles. Women with MFPP often experience severely reduced quality of life due to impaired sexual health. Here, we examined the relationship [...] Read more.
Introduction: Myofascial pelvic pain (MFPP) is a prevalent yet frequently overlooked condition characterized by myofascial trigger points located within the pelvic floor muscles. Women with MFPP often experience severely reduced quality of life due to impaired sexual health. Here, we examined the relationship between MFPP and sexual function. Materials and Methods: Eighty-three women with a benign gynecological condition were included in this pilot study. For each patient, we obtained a complete medical history, measured different types of subjective pain intensity using a visual analog scale, performed a validated standardized examination of the pelvic floor muscles for measuring MFPP, and used the German Female Sexual Function Index (FSFI-d) questionnaire. Results: Compared to women without MFPP (46 out of 83; 55.4%), the women with MFPP (37 out of 83; 44.6%) reported experiencing pain on more days per month (8 vs. 3 days/month; p = 0.002) and higher median VAS scores for dyspareunia (4 vs. 0; p < 0.001). We also found a significant inverse correlation between the severity of MFPP and overall FSFI-d scores (r = −0.35; p < 0.001), particularly in the FSFI-d subdomains of pain (r = −0.364; p < 0.001), lubrication (r = −0.230; p = 0.005), and arousal (r = −0.360; p < 0.001). Conclusions: Due to the higher prevalence of dyspareunia and pelvic pain, MFPP significantly impacts several aspects of female sexual health and function. This information, combined with increased awareness regarding MFPP, may provide a foundation for designing individualized therapies, thereby improving the quality of life of women affected by MFPP. Full article
(This article belongs to the Section Obstetrics & Gynecology)
Show Figures

Figure 1

Figure 1
<p>Comparison of internal palpation examination score (<b>A</b>), dysmenorrhea (<b>B</b>), pain symptoms (<b>C</b>), and dyspareunia (<b>D</b>) in women with and without MFPP. (<b>A</b>) Summary of internal palpation examination scores in the “no MFPP” and “MFPP” groups (<span class="html-italic">p</span> &lt; 0.001). (<b>B</b>) Summary of mean dysmenorrhea intensity scores in the “no MFPP” and “MFPP” groups measured using a visual analog scale (<span class="html-italic">p</span> = 0.168). (<b>C</b>) Summary of the mean number of days per month with acyclic pain in the “no MFPP” and “MFPP” groups (<span class="html-italic">p</span> = 0.002). (<b>D</b>) Summary of the mean intensity of dyspareunia in the “no MFPP” and “MFPP” groups measured using a visual analog scale (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 2
<p>Total FSFI-d scores plotted against internal palpation examination scores for all 83 participants (r = −0.35; <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">
20 pages, 1249 KiB  
Article
User-Centric Cell-Free Massive MIMO with Low-Resolution ADCs for Massive Access
by Jin-Woo Kim, Hyoung-Do Kim, Kyung-Ho Shin, Sang-Wook Park, Seung-Hwan Seo, Yoon-Ju Choi, Young-Hwan You and Hyoung-Kyu Song
Sensors 2024, 24(16), 5088; https://doi.org/10.3390/s24165088 - 6 Aug 2024
Viewed by 472
Abstract
This paper proposes a heuristic association algorithm between access points (APs) and user equipment (UE) in user-centric cell-free massive multiple-input-multiple-output (MIMO) systems, specifically targeting scenarios where UEs share the same frequency and time resources. The proposed algorithm prevents overserving APs and ensures the [...] Read more.
This paper proposes a heuristic association algorithm between access points (APs) and user equipment (UE) in user-centric cell-free massive multiple-input-multiple-output (MIMO) systems, specifically targeting scenarios where UEs share the same frequency and time resources. The proposed algorithm prevents overserving APs and ensures the connectivity of all UEs, even when the number of UEs is significantly greater than the number of APs. Additionally, we assume the use of low-resolution analog-to-digital converters (ADCs) to reduce fronthaul capacity. While realistic massive access scenarios, such as those in Internet-of-Things (IoT) environments, often involve hundreds or thousands of UEs per AP using multiple access techniques to allocate different frequency and time resources, our study focuses on scenarios where UEs within each AP cluster share the same frequency and time resources to highlight the impact of pilot contamination in dense network environments. The proposed algorithm is validated through simulations, confirming that it guarantees the connection of all UEs and prevents overserving APs. Furthermore, we analyze the required fronthaul capacity based on quantization bits and confirm that the proposed algorithm outperforms existing algorithms in terms of SE and average SE performance for UEs. Full article
(This article belongs to the Section Sensor Networks)
Show Figures

Figure 1

Figure 1
<p>Cell-free massive MIMO system model.</p>
Full article ">Figure 2
<p>Average number of overserving APs and unconnected UEs for each algorithm.</p>
Full article ">Figure 3
<p>Spectral efficiency performance results based on the number of users and combining vectors.</p>
Full article ">Figure 3 Cont.
<p>Spectral efficiency performance results based on the number of users and combining vectors.</p>
Full article ">Figure 4
<p>Average SE based on the number of users, combining techniques, and quantization bit.</p>
Full article ">Figure 5
<p>Total required fronthaul capacity and total power consumption based on the quantization bit.</p>
Full article ">
14 pages, 501 KiB  
Article
Transforming Veteran Rehabilitation Care: Learnings from a Remote Digital Approach for Musculoskeletal Pain
by Anabela C. Areias, Dan Doverspike, Daniel F. Brostek, Dora Janela, Michael S. Erwin, John M. Pinter, James R. Ficke and Fabíola Costa
Healthcare 2024, 12(15), 1518; https://doi.org/10.3390/healthcare12151518 - 31 Jul 2024
Viewed by 712
Abstract
While musculoskeletal pain (MSP) stands as the most prevalent health condition among Veterans, timely and high-quality care is often hindered due to access barriers. Team Red, White & Blue (Team RWB), a nonprofit organization dedicated to promoting a healthier lifestyle among Veterans, aimed [...] Read more.
While musculoskeletal pain (MSP) stands as the most prevalent health condition among Veterans, timely and high-quality care is often hindered due to access barriers. Team Red, White & Blue (Team RWB), a nonprofit organization dedicated to promoting a healthier lifestyle among Veterans, aimed to assess innovative approaches to veteran care. This is a single-arm pilot study investigating the feasibility, clinical outcomes, engagement, and satisfaction of a remote multimodal digital care program among Veterans with MSP. The impact of deployment experience on outcomes was explored as a secondary aim. From 75 eligible Veterans, 61 started the program, reporting baseline pain frequently comorbid with mental distress. Program acceptance was suggested by the high completion rate (82%) and engagement levels, alongside high satisfaction (9.5/10, SD 1.0). Significant improvements were reported in all clinical outcomes: pain (1.98 points, 95%CI 0.13; 3.84, p = 0.036); mental distress, with those reporting at least moderate baseline depression ending the program with mild symptoms (8.50 points, 95%CI: 6.49; 10.51, p = 0.012); daily activity impairment (13.33 points, 95%CI 1.31; 25.34, p = 0.030). Deployed Veterans recovered similarly to their counterparts. Overall, the above results underscore the potential of a remote digital intervention to expand Veterans’ access to timely MSP care. Full article
(This article belongs to the Section TeleHealth and Digital Healthcare)
Show Figures

Figure 1

Figure 1
<p>Veteran pilot study flow chart.</p>
Full article ">
7 pages, 967 KiB  
Brief Report
Detecting Intrathoracic Airway Closure during Prehospital Cardiopulmonary Resuscitation Using Quasi-Static Pressure–Volume Curves: A Pilot Study
by Maxim Vanwulpen, Arthur Bouillon, Ruben Cornelis, Bert Dessers and Saïd Hachimi-Idrissi
J. Clin. Med. 2024, 13(14), 4274; https://doi.org/10.3390/jcm13144274 - 22 Jul 2024
Viewed by 503
Abstract
Background: Intrathoracic airway closure frequently occurs during cardiac arrest, possibly impairing ventilation. Previously, capnogram analysis was used to detect this pathophysiological process. In other populations, quasi-static pressure–volume curves obtained during constant low-flow inflations are routinely used to detect intrathoracic airway closure. This study [...] Read more.
Background: Intrathoracic airway closure frequently occurs during cardiac arrest, possibly impairing ventilation. Previously, capnogram analysis was used to detect this pathophysiological process. In other populations, quasi-static pressure–volume curves obtained during constant low-flow inflations are routinely used to detect intrathoracic airway closure. This study reports the first use of quasi-static pressure–volume curves to detect intrathoracic airway closure during prehospital cardiopulmonary resuscitation. Methods: Connecting a pressure and flow sensor to the endotracheal tube enabled the performance of low-flow inflations during cardiopulmonary resuscitation using a manual resuscitator. Users connected the device following intubation and performed a low-flow inflation during the next rhythm analysis when chest compressions were interrupted. Determining the lower inflection point on the resulting pressure–volume curves allowed for the detection and quantification of intrathoracic airway closure. Results: The research device was used during the prehospital treatment of ten cardiac arrest patients. A lower inflection point indicating intrathoracic airway closure was detected in all patients. During cardiac arrest, the median pressure at which the lower inflection point occurred was 5.56 cmH20 (IQR 4.80, 8.23 cmH20). This value varied considerably between cases and was lower in patients who achieved return of spontaneous circulation. Conclusions: In this pilot study, quasi-static pressure–volume curves were obtained during prehospital cardiopulmonary resuscitation. Intrathoracic airway closure was detected in all patients. Further research is needed to determine whether the use of ventilation strategies to counter intrathoracic airway closure could lead to improved outcomes and if the degree of airway closure could serve as a prognostic factor. Full article
(This article belongs to the Special Issue Cardiac Arrest in Intensive Care: Management and Prognosis)
Show Figures

Figure 1

Figure 1
<p>Research device—pressure-transducing catheter and custom coupling piece on the left, flow sensor on the right.</p>
Full article ">Figure 2
<p>Pressure–volume curve of a manual low-flow inflation—dotted lines indicate minimal and maximal compliance, and the pressure at which these lines intersect is defined as the lower inflection point.</p>
Full article ">Figure 3
<p>Scatter plot—time interval between the start of CPR and low-flow inflation is shown on the horizontal axis, calculated lower inflection point is shown on the vertical axis.</p>
Full article ">
10 pages, 1207 KiB  
Case Report
The Effects of Hybrid Tele Airway Clearance in Bronchiectasis Patients: A Case Series
by Aung Aung Nwe, Nimit Kosura, Chatchai Phimphasak, Pornthip Barnludech, Si Thu Aung, Worawat Chumpangern and Chulee Ubolsakka-Jones
Reports 2024, 7(3), 57; https://doi.org/10.3390/reports7030057 - 19 Jul 2024
Viewed by 425
Abstract
This study aims to evaluate the preliminary effects of a hybrid tele-supervised airway clearance protocol on secretion clearance, health-related quality of life, and patient satisfaction in bronchiectasis patients. A single-arm experimental pilot case series with three participants was conducted, involving six ACT sessions [...] Read more.
This study aims to evaluate the preliminary effects of a hybrid tele-supervised airway clearance protocol on secretion clearance, health-related quality of life, and patient satisfaction in bronchiectasis patients. A single-arm experimental pilot case series with three participants was conducted, involving six ACT sessions over three days, including one onsite supervised session and five tele-supervised sessions. Assessment measures comprised sputum expectoration, COPD assessment test (CAT), and participant satisfaction ratings. The results showed increased sputum expectoration rates during each ACT session, alongside notable improvements in CAT scores (reductions of 16, 8, and 8 points for each participant). Participants expressed high satisfaction with tele-supervised sessions and reported increased confidence in independent ACT performance post-program. The findings suggest that the hybrid ACT program may be a promising avenue for enhancing bronchiectasis management. However, further research with larger sample sizes and rigorous control groups is necessary to validate its efficacy and broader applicability. Full article
(This article belongs to the Section Orthopaedics/Rehabilitation/Physical Therapy)
Show Figures

Figure 1

Figure 1
<p>Schematic comparison of original FET and mFET.</p>
Full article ">Figure 2
<p>A set of modified mFET.</p>
Full article ">Figure 3
<p>Rate per hour of sputum expectoration in the run-in phase and intervention phase. Data are presented as mean and standard deviation.</p>
Full article ">
15 pages, 1099 KiB  
Article
Development and Validation of a Tool to Explore Attitudes Towards meDication adHErence Using a Novel Self-Reported QuestionnairE (ADHERE-7)
by Iva Bužančić, Mislav Balen, Dahna Arbanas, Slaven Falamić, Katarina Fehir Šola, Ana Galić Skoko, Mirna Momčilović, Ante Orbanić, Alena Tatarević and Maja Ortner Hadžiabdić
Pharmacy 2024, 12(4), 113; https://doi.org/10.3390/pharmacy12040113 - 18 Jul 2024
Viewed by 580
Abstract
Despite the availability of various tools for measuring medication adherence, efficiently identifying non-adherence levels and reasons at the point of care remains challenging. Existing tools often lack the ease of use needed for practical clinical application. This study aimed to develop and validate [...] Read more.
Despite the availability of various tools for measuring medication adherence, efficiently identifying non-adherence levels and reasons at the point of care remains challenging. Existing tools often lack the ease of use needed for practical clinical application. This study aimed to develop and validate a user-friendly tool to provide healthcare professionals with a concise yet comprehensive means of identifying adherence behaviors. The methodology consisted of two phases: tool items were first developed using the nominal group technique with healthcare professionals, followed by a cross-sectional pilot study involving community-dwelling adults in Croatia. Validation analysis indicated acceptable face and content validity and satisfactory criterion validity, with Attitudes towards meDication adHErence self-Reported questionnairE (ADHERE-7) scores correlating with both the self-reported five-item Medication Adherence Report Scale (MARS-5 tool) (ρ = 0.765; p < 0.001) and an objective measure of the proportion of days covered (PDC) from pharmacy prescription claims data (G = 0.586; p = 0.015). Construct validity revealed three factors: Aversion, Comfort, and Practical Non-Adherence, with Cronbach’s alpha values of 0.617 for Aversion and 0.714 for Comfort Non-Adherence. The mean total score for ADHERE-7 was 26.27 ± 2.41 (range 17 to 28). This robust validation process confirms the ADHERE-7 tool as a reliable instrument for assessing medication adherence, addressing aversion, comfort, practical issues, and both intentional and unintentional nonadherence. Full article
(This article belongs to the Special Issue Innovations in Clinical Pharmacy: Towards Optimized Patient Care)
Show Figures

Figure 1

Figure 1
<p>Distribution of factor and tool scores.</p>
Full article ">Figure 2
<p>Answers to ADHERE-7.</p>
Full article ">Scheme 1
<p>Tool development and validation process.</p>
Full article ">
13 pages, 4236 KiB  
Article
Regeneration of Osteochondral Lesion of the Talus with Retrograde Drilling Technique: An In Vitro Pilot Study
by Francesca Veronesi, Melania Maglio, Silvia Brogini, Antonio Mazzotti, Elena Artioli, Simone Ottavio Zielli, Cesare Faldini and Gianluca Giavaresi
J. Clin. Med. 2024, 13(14), 4138; https://doi.org/10.3390/jcm13144138 - 16 Jul 2024
Viewed by 579
Abstract
Background: Retrograde Drilling (RD) is a surgical technique employed for osteochondral lesions of the talus (OCLTs) to reach the subchondral bone lesion from behind, thus preserving cartilage integrity. The aim of the present pilot study was to set up an in vitro model [...] Read more.
Background: Retrograde Drilling (RD) is a surgical technique employed for osteochondral lesions of the talus (OCLTs) to reach the subchondral bone lesion from behind, thus preserving cartilage integrity. The aim of the present pilot study was to set up an in vitro model of OCLTs to evaluate the regenerative potential of biological approaches that could be associated with the RD technique. Methods: For this purpose, an OCLT was created in human osteochondral specimens, to try to mimic the RD technique, and to compare the regenerative potential of two biological treatments. For this purpose, three groups of treatments were performed in vitro: (1) no treatment (empty defect); (2) autologous bone graft (ABG); (3) hyaluronic membrane enriched with autologous bone marrow cells. Tissue viability; production of Collagen I and II, Vascular Endothelial Growth Factor, and Aggrecan; and histological and microCT evaluations were performed after 30 days of culture in normal culture conditions. Results: It was observed that Group 3 showed the highest viability, and Group 2 showed the highest protein production. From a histological and microtomographic point of view, it was possible to appreciate the structure of the morcellized bone with which the defect of Group 2 was filled, while it was not yet possible to observe the deposition of mineralized tissue in Group 3. Conclusions: To conclude, this pilot study shows the feasibility of an alternative in vitro model to evaluate and compare the regenerative potential of two biological scaffolds, trying to mimic the RD technique as much as possible. The tissues remained vital for up to 4 weeks and both ABG and hyaluronic acid-based scaffolds stimulated the release of proteins linked to regenerative processes in comparison to the empty defect group. Full article
(This article belongs to the Special Issue Clinical Perspectives in Trauma and Orthopedic Surgery)
Show Figures

Figure 1

Figure 1
<p>Identification of the VOI for the morphometric microCT analysis: (<b>a</b>) complete 3D rendering of a representative sample from Group 2, with the volume corresponding to the defect highlighted in red; (<b>b</b>) subtraction of the measured VOI from the 3D rendering of the sample; (<b>c</b>) 3D rendering of the VOI corresponding to the defect.</p>
Full article ">Figure 2
<p>Histograms of osteochondral defect culture viability of Groups 1, 2, and 3. T2: ** Group 2 vs. Group 1 (<span class="html-italic">p</span> = 0.004); ** Group 3 vs. Group 1 (<span class="html-italic">p</span> = 0.006); * Group 3 vs. Group 2 (<span class="html-italic">p</span> = 0.01). T4: *** Group 2 and Group 3 vs. Group 1 (<span class="html-italic">p</span> &lt; 0.001); * Group 3 vs. Group 2 (<span class="html-italic">p</span> = 0.01). c T2 vs. T0 and T4 vs. T2 (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 3
<p>Histograms of COLL I (<b>A</b>), VEGF (<b>B</b>), Aggrecan (<b>C</b>), and COLL II (<b>D</b>) of Groups 1, 2, and 3. COLL I, VEGF, Aggrecan: ***, Group 2 and Group 3 vs. Group 1 (<span class="html-italic">p</span> &lt; 0.001); Group 2 vs. Group 1 (<span class="html-italic">p</span> &lt; 0.001). COLL II: ***, Group 2 vs. Group 1 and Group 3 (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 4
<p>Representative 3D rendering of samples from Group 1 (<b>a</b>), Group 2 (<b>b</b>), and Group 3 (<b>c</b>).</p>
Full article ">Figure 5
<p>Histograms of microtomographic parameters BV/TV (<b>A</b>), Tb.Th (<b>B</b>), and Tb.Sp (<b>C</b>) of Groups 1, 2, and 3 (n = 3 replicates). BV/TV: *, Group 3 vs. Group 1 (<span class="html-italic">p</span> = 0.03); **, Group 2 vs. Group 1 (<span class="html-italic">p</span> = 0.002); **, Group 2 vs. Group 3 (<span class="html-italic">p</span> = 0.003). Tb.Th: ***, Group 2 vs. Group 1 and Group 3 (<span class="html-italic">p</span> &lt; 0.001). Tb.Sp: ***, Group 3 vs. Group 2 (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 6
<p>Histological overview of Group 1 (<b>a</b>), Group 2 (<b>c</b>), and Group 3 (<b>e</b>). Magnification 2×. Safranin O/Fast Green staining. Details of interface between articular cartilage, surrounding bone, and defect of Group 1 (<b>b</b>) and Group 3 (<b>f</b>) and of defect filled with ABG in Group 2 (<b>d</b>). Magnification 20×. Safranin O/Fast Green staining.</p>
Full article ">
16 pages, 4186 KiB  
Article
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients
by Antonio D’Ambrosio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino and Vincenzo Piemonte
Bioengineering 2024, 11(7), 710; https://doi.org/10.3390/bioengineering11070710 - 12 Jul 2024
Viewed by 713
Abstract
Growing evidence suggests that impaired gut permeability and gut microbiota alterations are involved in the pathogenesis of Inflammatory Bowel Diseases (IBDs), which include Ulcerative Colitis (UC) and Crohn’s Disease (CD). Vedolizumab is an anti-α4β7 antibody approved for IBD treatment, used as the first [...] Read more.
Growing evidence suggests that impaired gut permeability and gut microbiota alterations are involved in the pathogenesis of Inflammatory Bowel Diseases (IBDs), which include Ulcerative Colitis (UC) and Crohn’s Disease (CD). Vedolizumab is an anti-α4β7 antibody approved for IBD treatment, used as the first treatment or second-line therapy when the first line results in inadequate effectiveness. The aim of this study is to develop a mathematical model capable of describing the pathophysiological mechanisms of Vedolizumab treatment in IBD patients. In particular, the relationship between drug concentration in the blood, colonic mucosal permeability and fecal microbiota composition was investigated and modeled to detect and predict trends in order to support and tailor Vedolizumab therapies. To pursue this aim, clinical data from a pilot study on a cluster of 11 IBD patients were analyzed. Enrolled patients underwent colonoscopy in three phases (before (t0), after 24 weeks of (t1) and after 52 weeks of (t2 ) Vedolizumab treatment) to collect mucosal biopsies for transepithelial electrical resistance (TEER) evaluation (permeability to ions), intestinal permeability measurement and histological analysis. Moreover, fecal samples were collected for the intestinal microbiota analysis at the three time points. The collected data were compared to those of 11 healthy subjects at t0, who underwent colonoscopy for screening surveillance, and used to implement a three-compartmental mathematical model (comprising central blood, peripheral blood and the intestine). The latter extends previous evidence from the literature, based on the regression of experimental data, to link drug concentration in the peripheral blood compartment with Roseburia abundance and intestinal permeability. The clinical data showed that Vedolizumab treatment leads to an increase in TEER and a reduction in intestinal permeability to a paracellular probe, improving tissue inflammation status. Microbiota analysis showed increasing values of Roseburia, albeit not statistically significant. This trend was adequately reproduced by the mathematical model, which offers a useful tool to describe the pathophysiological effects of Vedolizumab therapy on colonic mucosal permeability and fecal microbiota composition. The model’s satisfactory predictive capabilities and simplicity shed light on the relationship between the drug, the microbiota and permeability and allow for its straightforward extension to diverse therapeutic conditions. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Flow chart of the pilot clinical study [<a href="#B42-bioengineering-11-00710" class="html-bibr">42</a>].</p>
Full article ">Figure 2
<p>Representation of the three-compartmental model. Each compartment is described by a perfectly mixed reactor.</p>
Full article ">Figure 3
<p>Comparison between microbiota compositions of IBD patients at phases <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math> for the four major phyla (<span class="html-italic">Actinobacteria</span>, <span class="html-italic">Bacteroidetes</span>, <span class="html-italic">Proteobacteria</span> and <span class="html-italic">Firmicutes</span>). Data are expressed in relative abundance.</p>
Full article ">Figure 4
<p>Bacterial density of <span class="html-italic">Roseburia</span> in phases <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>1</mn> </mrow> </msub> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math>.</p>
Full article ">Figure 5
<p>Comparison between TEER values in IBD patients at phase <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math> (dark grey) and in the control group.</p>
Full article ">Figure 6
<p>Comparison between TEER values at phases <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math> (dark grey) and <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math> (light grey) in IBD patients.</p>
Full article ">Figure 7
<p>Comparison between intestinal permeability <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>P</mi> </mrow> <mrow> <mi>m</mi> </mrow> </msub> </mrow> </semantics></math> values at phases <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math> (dark grey) and <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math> (light grey) in IBD patients.</p>
Full article ">Figure 8
<p>Comparison between RHI at phases <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>0</mn> </mrow> </msub> </mrow> </semantics></math> (dark grey) and <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>t</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math> (light grey) in IBD patients.</p>
Full article ">Figure 9
<p>PMS (<b>a</b>) and RHI (<b>b</b>) trends over time in UC patients.</p>
Full article ">Figure 10
<p>HBI (<b>a</b>) and RHI (<b>b</b>) trends over time in CD patients.</p>
Full article ">Figure 11
<p>(<b>a</b>) Vedolizumab concentration in central blood compartment over time predicted by the model, compared to data from the literature [<a href="#B28-bioengineering-11-00710" class="html-bibr">28</a>] (dots). (<b>b</b>) Vedolizumab concentration in the peripheral blood compartment over time predicted by the model. (<b>c</b>) Intestinal concentration of MAdCAM-1 over time predicted by the model, compared to data from the literature [<a href="#B53-bioengineering-11-00710" class="html-bibr">53</a>] (dots).</p>
Full article ">Figure 12
<p><span class="html-italic">Roseburia</span> abundance (<b>a</b>) and intestinal permeability (<b>b</b>) trends over Vedolizumab concentration in central blood compartment, as predicted by the model and derived from the clinical study (dots).</p>
Full article ">Figure 13
<p><span class="html-italic">Roseburia</span> abundance (<b>a</b>) and intestinal permeability (<b>b</b>) trends over time, as predicted by the model and derived from the clinical study (dots).</p>
Full article ">Figure 14
<p>Parity plots between the model output and the experimental data for different variables: (<b>a</b>) the concentrations of Vedolizumab <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>C</mi> </mrow> <mrow> <mn>1</mn> </mrow> </msub> </mrow> </semantics></math> and MAdCAM-1 <math display="inline"><semantics> <mrow> <mi>M</mi> </mrow> </semantics></math>, and (<b>b</b>) the intestinal permeability <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>P</mi> </mrow> <mrow> <mi>m</mi> </mrow> </msub> </mrow> </semantics></math> and <span class="html-italic">Roseburia</span> abundance <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>C</mi> </mrow> <mrow> <mi>b</mi> </mrow> </msub> </mrow> </semantics></math>.</p>
Full article ">
10 pages, 4041 KiB  
Article
Perfusion in Pedicled Skin Flaps: Initial Insights from Smartphone-Based Thermal Imaging Protocol
by Lukas S. Fiedler, Burkard M. Lippert, Lukas Adrian and Tobias Meyer
J. Pers. Med. 2024, 14(7), 730; https://doi.org/10.3390/jpm14070730 - 5 Jul 2024
Cited by 1 | Viewed by 391
Abstract
Objective: Successful outcomes in head and neck surgery rely on maintaining perfusion in pedicled skin flaps. Thermal imaging offers a noninvasive means to assess tissue perfusion, potentially aiding in predicting flap viability. This pilot study explores the utility of SBTI (smartphone-based thermal imaging) [...] Read more.
Objective: Successful outcomes in head and neck surgery rely on maintaining perfusion in pedicled skin flaps. Thermal imaging offers a noninvasive means to assess tissue perfusion, potentially aiding in predicting flap viability. This pilot study explores the utility of SBTI (smartphone-based thermal imaging) for predicting flap vitality and monitoring during surgery. Methods: Thermal imaging was employed using the FLIR One System. An imaging protocol was established, defining points of interest (T1-T4) on pedicled skin flaps. Conducted over four months, the study integrated SBTI into reconstructive surgery for the face, head and neck defects post-tumor resections. SBTI’s effectiveness was assessed with n = 11 pedicled flaps, capturing images at key stages and correlating them with clinical flap assessment. Thermal images were retrospectively graded by two surgeons, evaluating flap perfusion on a scale from 1 to 5, based on temperature differences (1 = ΔT < 2 °C, 2 = ΔT ≥ 2 °C, 3 = ΔT ≥ 4 °C, 4 = ΔT ≥ 6 °C, and 5 = ΔT ≥ 8 °C), with assessments averaged for consensus and compared with the clinical assessment control group. Results: The study encountered challenges during implementation, leading to the exclusion of six patients. Patient data included 11 cases with n = 44 SBTI images. Intraoperative assessments consistently showed good perfusion. One postoperative dehiscence was noted, which retrospectively coincided with intraoperative SBTI grading, but not with clinical assessment. Statistical analysis indicated consistent outcomes following clinical and SBTI assessments. Thermal imaging accurately predicted flap viability, although it had limitations with small flaps. Conclusion: SBTI proved effective, inexpensive, and noninvasive for assessing tissue perfusion, showing promise for predicting flap viability and intraoperative monitoring in head and neck surgery. Full article
(This article belongs to the Special Issue Clinical Applications of Biospectroscopy and Imaging)
Show Figures

Figure 1

Figure 1
<p>SBTI algorithm.</p>
Full article ">Figure 2
<p>Implemented SBTI algorithm T1–4, showing the intraoperative picture in correlation to the SBTI picture.</p>
Full article ">Figure 3
<p>Rainbow temperature scale.</p>
Full article ">Figure 4
<p>Perioperative thermal imaging in a random pattern flap with the FLIR one Pro Camera preoperatively (<b>left</b>), after flap elevation, after reconstruction, and 24 h after surgery (<b>right</b>) showing good perfusion due to the red color and minor yellow area in the periphery, which shows a low delta between normal and flap temperature.</p>
Full article ">Figure 5
<p>Perioperative thermal imaging in a combined reconstruction preoperatively (<b>left</b>), after flap elevation (<b>middle</b>), and after reconstruction (<b>right</b>) showing good perfusion due to a homogenous yellowish color emitted by the flaps (modified Hatchet and Esser flap).</p>
Full article ">
13 pages, 1676 KiB  
Article
Centhaquine Increases Stroke Volume and Cardiac Output in Patients with Hypovolemic Shock
by Aman Khanna, Krish Vaidya, Dharmesh Shah, Amaresh K. Ranjan and Anil Gulati
J. Clin. Med. 2024, 13(13), 3765; https://doi.org/10.3390/jcm13133765 - 27 Jun 2024
Viewed by 608
Abstract
Introduction: Centhaquine is a resuscitative agent that acts on α2B adrenergic receptors. Its effect on cardiac output in hypovolemic shock patients has not been reported. Methods: This pilot study was conducted in 12 hypovolemic shock patients treated with centhaquine who participated in an [...] Read more.
Introduction: Centhaquine is a resuscitative agent that acts on α2B adrenergic receptors. Its effect on cardiac output in hypovolemic shock patients has not been reported. Methods: This pilot study was conducted in 12 hypovolemic shock patients treated with centhaquine who participated in an open-label phase IV study (NCT05956418). Echocardiography was utilized to measure stroke volume (SV), cardiac output (CO), left ventricular outflow tract velocity time integral (LVOT-VTI) and diameter (LVOTd), heart rate (HR), left ventricular ejection fraction (LVEF) and fractional shortening (LVFS), and inferior vena cava (IVC) diameter before (0 min) and 60, 120, and 300 min after centhaquine (0.01 mg/kg) iv infusion for 60 min. Results: SV was significantly increased after 60, 120, and 300 min. CO increased significantly after 120 and 300 min despite a decrease in HR. IVC diameter and LVOT-VTI at these time points significantly increased, indicating the increased venous return. LVEF and LVFS did not change, while the mean arterial pressure (MAP, mmHg) increased after 120 and 300 min. Positive correlations between IVC diameter and SV (R2 = 0.9556) and between IVC diameter and MAP (R2 = 0.8928) were observed, which indicated the effects of an increase in venous return on SV, CO, and MAP. Conclusions: Centhaquine-mediated increase in venous return is critical in enhancing SV, CO, and MAP in patients with hypovolemic shock; these changes could be pivotal for reducing shock-mediated circulatory failure, promoting tissue perfusion, and improving patient outcomes. Trial Registration: CTRI/2021/01/030263 and NCT05956418. Full article
(This article belongs to the Special Issue Emergency Medicine in Cardiovascular Diseases)
Show Figures

Figure 1

Figure 1
<p>Effects of centhaquine on cardiovascular variables (SV, CO, HR, and MAP) (<b>A</b>–<b>D</b>). ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, and **** <span class="html-italic">p</span> &lt; 0.0001, ns—not significant compared to 0 min. <span class="html-italic">n</span> = 12.</p>
Full article ">Figure 2
<p>Effect of centhaquine on venous return (IVC diameter) (<b>A</b>) and its correlation with SV (<b>B</b>) and MAP (<b>C</b>), ** <span class="html-italic">p</span> &lt; 0.01, and **** <span class="html-italic">p</span> &lt; 0.0001 compared to 0 min. <span class="html-italic">n</span> = 12.</p>
Full article ">Figure 3
<p>Effect of centhaquine on blood flow (LVOT-VTI) in LVOT to aorta (<b>A</b>), its correlation with IVC diameter (<b>B</b>), on LVOT diameter (<b>C</b>) and LVOT area (<b>D</b>). * <span class="html-italic">p</span> &lt; 0.05, and **** <span class="html-italic">p</span> &lt; 0.0001, ns not significant, compared to 0 min. <span class="html-italic">n</span> = 12.</p>
Full article ">
14 pages, 908 KiB  
Article
The Potential Benefits of Acute Aronia Juice Supplementation on Physical Activity Induced Alterations of the Serum Protein Profiles in Recreational Runners: A Pilot Study
by Tamara Uzelac, Marija Takić, Vuk Stevanović, Nevena Vidović, Ana Pantović, Petar Jovanović and Vesna Jovanović
Healthcare 2024, 12(13), 1276; https://doi.org/10.3390/healthcare12131276 - 26 Jun 2024
Viewed by 1031
Abstract
Intensive physical activity (PA) can lead to proteinuria and, consequently, serum protein profiles in athletes. Therefore, the aim of this study was to investigate the effects of acute aronia juice consumption before a simulated half-marathon race on serum protein profiles in recreational runners. [...] Read more.
Intensive physical activity (PA) can lead to proteinuria and, consequently, serum protein profiles in athletes. Therefore, the aim of this study was to investigate the effects of acute aronia juice consumption before a simulated half-marathon race on serum protein profiles in recreational runners. The pilot study was designed as a single-blind, placebo-controlled, crossover study, with 10 male participants who consumed aronia juice (containing 1.3 g polyphenols) or placebo before the race. The blood levels of total proteins, albumin, the non-albumin fractions gamma, beta, alpha2 and alpha1, as well as renal function parameters, were determined before and 15 min, 1 h and 24 h after the race. The significant changes in urea, creatinine and uric acid levels were noticed at selected time points in both groups. In the placebo group, a significant decrease in total proteins (p < 0.05) was observed 24 h after the race, along with an increase in gamma fraction abundance (p < 0.05). In addition, urea and uric acid levels returned to baseline only in the aronia group 24 h after the race. Thus, according to the results obtained, acute aronia juice supplementation before intensive PA could influence the transient change in renal function and PA-induced protein loss in recreational runners. Full article
(This article belongs to the Special Issue Nutrition and Supplementation for Human Performance)
Show Figures

Figure 1

Figure 1
<p>Summary of research design.</p>
Full article ">Figure 2
<p>Total proteins, HSA, and non-albumin proteins (g/L) in serum before, 24 h and 7 days after the first simulated half-marathon race. * <span class="html-italic">p</span> ˂ 0.05 compared to value before 1st race.</p>
Full article ">
17 pages, 1173 KiB  
Systematic Review
Fucoidan as a Promising Drug for Pain Treatment: Systematic Review and Meta-Analysis
by Miguel Á. Huerta, Miguel Á. Tejada and Francisco R. Nieto
Mar. Drugs 2024, 22(7), 290; https://doi.org/10.3390/md22070290 - 24 Jun 2024
Viewed by 2446
Abstract
Fucoidan is a polymer of L-fucose and L-fucose-4-sulphate naturally found in marine sources that inhibits p-selectin, preventing neutrophil recruitment to the site of injury. Fucoidan is employed in many studies as a tool to investigate the contribution of neutrophils to pain, showing analgesic [...] Read more.
Fucoidan is a polymer of L-fucose and L-fucose-4-sulphate naturally found in marine sources that inhibits p-selectin, preventing neutrophil recruitment to the site of injury. Fucoidan is employed in many studies as a tool to investigate the contribution of neutrophils to pain, showing analgesic effects. We performed a systematic review and meta-analysis to quantify the analgesic effects of pretreatment with fucoidan reported in the available preclinical studies. In addition, we summarized the articles which have studied the therapeutic effects of fucoidan in pathological pain at preclinical and clinical levels. The results of this systematic review reveal that pretreatment with fucoidan is a powerful tool which reduces neutrophil infiltration by 70–90% at early time points. This meta-analysis showed that preventative treatment with fucoidan produced a significant pain reduction. In addition, several preclinical studies have observed that fucoidan treatment reduces the pain that is associated with various pathologies. Finally, fucoidan has also been tested in several clinical trials, with some degree of analgesic efficacy, but they were mostly small pilot studies. Considering all the above information, it can be concluded that fucoidan is not only a preclinical tool for studying the role of neutrophils in pain but also a promising therapeutic strategy for pain treatment. Full article
(This article belongs to the Section Marine Pharmacology)
Show Figures

Figure 1

Figure 1
<p>Study selection PRISMA flow diagram.</p>
Full article ">Figure 2
<p>Forest plot of the pain reduction efficacy of pretreatment with fucoidan. CI, confidence interval; RE, random effects [<a href="#B62-marinedrugs-22-00290" class="html-bibr">62</a>,<a href="#B63-marinedrugs-22-00290" class="html-bibr">63</a>,<a href="#B64-marinedrugs-22-00290" class="html-bibr">64</a>,<a href="#B65-marinedrugs-22-00290" class="html-bibr">65</a>,<a href="#B66-marinedrugs-22-00290" class="html-bibr">66</a>,<a href="#B68-marinedrugs-22-00290" class="html-bibr">68</a>,<a href="#B69-marinedrugs-22-00290" class="html-bibr">69</a>,<a href="#B71-marinedrugs-22-00290" class="html-bibr">71</a>,<a href="#B72-marinedrugs-22-00290" class="html-bibr">72</a>,<a href="#B73-marinedrugs-22-00290" class="html-bibr">73</a>,<a href="#B74-marinedrugs-22-00290" class="html-bibr">74</a>,<a href="#B75-marinedrugs-22-00290" class="html-bibr">75</a>,<a href="#B76-marinedrugs-22-00290" class="html-bibr">76</a>,<a href="#B77-marinedrugs-22-00290" class="html-bibr">77</a>,<a href="#B78-marinedrugs-22-00290" class="html-bibr">78</a>,<a href="#B79-marinedrugs-22-00290" class="html-bibr">79</a>,<a href="#B80-marinedrugs-22-00290" class="html-bibr">80</a>,<a href="#B82-marinedrugs-22-00290" class="html-bibr">82</a>,<a href="#B85-marinedrugs-22-00290" class="html-bibr">85</a>,<a href="#B86-marinedrugs-22-00290" class="html-bibr">86</a>,<a href="#B87-marinedrugs-22-00290" class="html-bibr">87</a>,<a href="#B90-marinedrugs-22-00290" class="html-bibr">90</a>,<a href="#B91-marinedrugs-22-00290" class="html-bibr">91</a>,<a href="#B92-marinedrugs-22-00290" class="html-bibr">92</a>,<a href="#B94-marinedrugs-22-00290" class="html-bibr">94</a>].</p>
Full article ">
Back to TopTop